Mondor disease: a case report in ED

Belleflamme, Marie; Penaloza, Andréa; Thoma, Maximilien; Hainaut, Philippe; Thys, Frédéric

doi:10.1016/j.ajem.2011.06.031

Cited by 15 publications

(12 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The disease is a self‐limiting condition, and the symptoms last for few weeks; and complete clinical resolution within 6 weeks is reported in most references. The complete resolution should be confirmed clinically and with follow‐up mammography and/or ultrasound .…”

Section: Discussionmentioning

confidence: 99%

The Effectiveness of Diclofenac Sodium in the Treatment of Mondor's Disease of the Breast: The Topical Patch Compared to the Oral Capsules

Shirah

Shirah²,

Alonazie³

2017

Breast J

View full text Add to dashboard Cite

Mondor's disease of the breast is a rare, benign sclerosing superficial thrombophlebitis of the subcutaneous veins of the anterior or lateral chest wall, which is treated conservatively. We aim in this study to evaluate the outcome and effectiveness of our treatment protocol using oral diclofenac sodium and topical diclofenac sodium patch in 172 patients. A retrospective database analysis of 172 female patients between January 2001 and December 2010 was done. The treatment protocol consisted of group 1: treatment by oral diclofenac sodium 100 mg once daily for 3 weeks. Group 2: treatment by diclofenac sodium patches for 8 hours twice daily (morning and evening) for 1 week. The patients were instructed to document the time as soon as pain relief is achieved following the patch application and the intake of the oral dose. The incidence rate was 2.49%. Diclofenac sodium patch was statistically found to be significantly better in subsiding the inflammatory process of the veins, relieving the pain, and enhancing faster healing rate. We conclude that diclofenac sodium patch showed a promising role in the treatment of Mondor's disease of the breast by significantly decreasing the inflammatory process due to its transdermal migration action within a short period and the ability to reach a high local concentration. It achieved the best results for rapid relief of pain and disease regression compared to the oral capsules. Therefore, our protocol was changed to implement diclofenac sodium patch as the first choice in treating Mondor's disease of the breast.

show abstract

Section: Discussionmentioning

confidence: 99%

The Effectiveness of Diclofenac Sodium in the Treatment of Mondor's Disease of the Breast: The Topical Patch Compared to the Oral Capsules

Shirah

Shirah²,

Alonazie³

2017

Breast J

View full text Add to dashboard Cite

show abstract

“…Antibiotics and prophylactic anticoagulation therapy are not recommended [16]. However, although no clear recommendation exists, some authors reported the administration of low-molecular-weight heparins considering the syndrome as a form of thrombophlebitis [3]. Low recurrence rates have been reported [11].…”

Section: Discussionmentioning

confidence: 99%

“…Through investigation is therefore mandatory to rule out an un-derlying malignancy. In addition, coagulation tests are recommended to exclude thrombophilic conditions [1,3,15].…”

Section: Discussionmentioning

confidence: 99%

Mondor's disease of the breast as a complication of ultrasound-guided core needle biopsy: Management and review of the literature

Salemis¹,

Vasilara

Lagoudianakis³

2015

View full text Add to dashboard Cite

Mondor's disease is a rare benign and self-limiting condition characterized by thrombophlebitis of the superficial veins of the anterolateral thoracoabdominal wall. We describe a case of Mondor's disease of the breast as a complication of an ultrasound-guided core needle biospy. The patient presented with a palpable cord-like structure in her left breast, associated with severe pain and tenderness. She was treated concervatively and complete resolution was observed after four weeks. We conclude that emergency clinicians and interventional breast radiologists should be aware of Mondor's disease as a potential complication of ultrasound-guided core needle biopsy of the breast.

show abstract

“…MRI angiography can also demonstrate thrombus and be used to evaluate extension of the thrombus, even into areas difficult or impossible to image with ultrasound or presence of hematoma; however, MRI is expensive and adds little to the clinical management of the disease [ 10 ]. Belleflamme et al have suggested ultrasound be the confirmatory imaging modality of choice [ 11 ].…”

Section: Discussionmentioning

confidence: 99%

“…Proper identification of Mondor's disease assisted by ultrasonography allows for proper management of the disease. Patients diagnosed in the emergency department should be given proper follow-up, which may include testing for protein C and protein S or antithrombin III deficiencies [ 3 ], evaluation for other thrombophilic conditions [ 11 ], and possible search for occult malignancy [ 1 , 11 ]. Treatment in the interim should consist of NSAIDs and cessation of intercourse [ 1 , 3 ].…”

Section: Discussionmentioning

confidence: 99%

Diagnosis of Mondor’s Disease in the Emergency Department with Bedside Ultrasound

O’Neal

Castleberg

Dinh

2015

Case Reports in Emergency Medicine

View full text Add to dashboard Cite

Mondor's disease is a rare condition characterized by a superficial thrombophlebitis that can occur in the thoracoabdominal and genital areas. Findings with ultrasound in penile Mondor's disease are readily measurable: a noncompressible penile vein without flow and absence of tears of the corpus cavernosum or tunica albuginea, hematoma, or evidence of fracture of the penis. We present a case of Mondor's disease, diagnosed with bedside ultrasound, in the emergency department. Ultrasonography is readily available within the emergency department, and we suggest its use in aiding diagnosis of genitourinary disorders such as Mondor's disease.

show abstract

Mondor disease: a case report in ED

Cited by 15 publications

References 12 publications

The Effectiveness of Diclofenac Sodium in the Treatment of Mondor's Disease of the Breast: The Topical Patch Compared to the Oral Capsules

The Effectiveness of Diclofenac Sodium in the Treatment of Mondor's Disease of the Breast: The Topical Patch Compared to the Oral Capsules

Mondor's disease of the breast as a complication of ultrasound-guided core needle biopsy: Management and review of the literature

Diagnosis of Mondor’s Disease in the Emergency Department with Bedside Ultrasound

Contact Info

Product

Resources

About